Controversies Challenges Consensus
}

Number of vascular surgeons being trained is “woefully inadequate”

2020-03-09T14:43:42+00:00

Sophie Renton (London, UK) moderates a session with Michel Makaroun (Pittsburgh, USA) and Armando Mansilha (Porto, Portugal) where the trio discuss some of the challenges relating to recruitment within the field of vascular surgery.

Makaroun explains that there are two main recruitment pathways into vascular surgery in the USA but notes […]

Number of vascular surgeons being trained is “woefully inadequate”2020-03-09T14:43:42+00:00

CX 2020: What to expect from this year’s Aortic Workshop

2020-03-09T10:48:40+00:00

Kevin Mani (Uppsala, Sweden) chats to BLearning about the upcoming Aortic Workshop at CX 2020 (Charing Cross Symposium; 21–24 April, London, UK), noting how the sessions will give attendees access to experts, the latest technologies and provide a platform for hands-on experience with new devices and imaging technology.

Workshop participants can take this […]

CX 2020: What to expect from this year’s Aortic Workshop2020-03-09T10:48:40+00:00

Michel Makaroun discusses why the CX Symposium is a “special meeting”

2020-03-09T09:09:07+00:00

Roger Greenhalgh (London, UK) speaks to former president of the SVS (2018–2019) Michel Makaroun (Pittsburgh, USA) about the CX Symposium which Makaroun says “always has a special flavour” and is “a special meeting”. Makaroun also touches on some of the similarities and differences between CX and the SVS meeting in […]

Michel Makaroun discusses why the CX Symposium is a “special meeting”2020-03-09T09:09:07+00:00

Long-term partnership helps drive CX Symposium forward

2020-03-06T09:50:48+00:00

Roger Greenhalgh (London, UK) and W L Gore’s Michael Koenke (Flagstaff, USA), take a look back at the history of the Charing Cross Symposium (CX), which began in 1978.

Koenke says that CX is a “special meeting for us”, adding that it is an “opportunity for us to connect with our […]

Long-term partnership helps drive CX Symposium forward2020-03-06T09:50:48+00:00

Scientific level of CX Symposium “very attractive” for attendees

2020-03-06T09:55:51+00:00

Roger Greenhalgh (London, UK) chats with Enrico Ascher (New York, USA) about some of the highlights of the CX Symposium, how it differs to the VEITH symposium in the USA and also how the two complement each other.

Ascher says he is always “totally amazed by the scientific level” of CX, […]

Scientific level of CX Symposium “very attractive” for attendees2020-03-06T09:55:51+00:00

CX 2019: A Latin American perspective in vascular and endovascular surgery

2020-03-02T14:30:44+00:00

Alberto Muñoz (Bogota, Colombia) talks to BLearning at CX 2019 (Charing Cross Symposium; 15–18 April, London, UK) about how the meeting provides a “great opportunity” to update attendees on the latest in vascular and endovascular surgery.

Muñoz goes on to highlight the international flavour of Charing Cross and notes the importance of the […]

CX 2019: A Latin American perspective in vascular and endovascular surgery2020-03-02T14:30:44+00:00

Highlights from the CX 2019 session, Paclitaxel: The last word

2019-09-06T16:04:24+01:00

The 2019 Charing Cross Symposium (CX; 15–18 April, London, UK) featured an in-depth highlight session on the paclitaxel controversy. […]

Highlights from the CX 2019 session, Paclitaxel: The last word2019-09-06T16:04:24+01:00

With CoveredSeal, Valiant Navion™ offers physicians the “best of both worlds” for TEVAR procedures

2019-09-06T16:05:44+01:00

Paul Hayes (Cambridge, UK), Frank Arko (Charlotte, USA) and Fabio Verzini (Turin, Italy) discuss the Valiant Navion™ (Medtronic) live thoracic endovascular aortic repair (TEVAR) case at Charing Cross 2019, which demonstrated the use of the new CoveredSeal proximal configuration.

Hayes talks about the accuracy of the device’s deployment around the thoracic […]

With CoveredSeal, Valiant Navion™ offers physicians the “best of both worlds” for TEVAR procedures2019-09-06T16:05:44+01:00

New APERTO AVF RCT data show DCB reduces restenosis significantly more than high-pressure balloon alone

2019-09-06T16:10:43+01:00

Matteo Tozzi (Varese, Italy) discusses new data from the APERTO AVF study, the first randomised trial in China to compare the safety and efficacy of the APERTO drug-coated balloon (DCB; Cardionovum) with a high-pressure balloon. The trial results for the treatment of failing haemodialysis arteriovenous shunts were presented by Qizhuang […]

New APERTO AVF RCT data show DCB reduces restenosis significantly more than high-pressure balloon alone2019-09-06T16:10:43+01:00

TEVAR performed outside the IFU has “dramatically worse outcomes”

2019-09-06T16:11:31+01:00

Dittmar Boeckler (Heidelberg, Germany) tells CX Live that treating patients with thoracic endovascular aortic repair (TEVAR) outside the instructions for use (IFU) has a dramatic effect on patient outcomes after the procedure. “We observed a significant increase in mortality […] an increased reintervention rate and four times higher endoleak rate,” […]

TEVAR performed outside the IFU has “dramatically worse outcomes”2019-09-06T16:11:31+01:00

CX 2019: Highlights from the inaugural iWounds Workshop

2019-09-06T16:16:14+01:00

Michael Edmonds (London, UK), Thomas Serena (Warren, USA), Keith Harding (Cardiff, UK), and Williams Ennis (Oak Lawn, USA) talk at CX Live about the first ever iWounds workshop, the importance of wound management and what they hope to achieve.

Edmonds discusses why “too many legs are being lost” and Serena talks […]

CX 2019: Highlights from the inaugural iWounds Workshop2019-09-06T16:16:14+01:00

Hear the latest thoughts on paclitaxel from global experts: their current practice and patient conversations

2019-09-06T16:19:25+01:00

Following the latest information presented at the Charing Cross International Symposium related to the meta-analysis of paclitaxel-coated devices (Katsanos et al, JAHA), hear from a multi-specialty panel of global experts who are discussing their current practice and the way they […]

Hear the latest thoughts on paclitaxel from global experts: their current practice and patient conversations2019-09-06T16:19:25+01:00

Don’t miss: The influence of hyperglycaemia on spinal cord injury

2019-09-06T16:21:31+01:00

Jade Hiramoto (San Francisco, USA) tells CX Live about why she believes “everyone should consider normalising glucose levels after long, complex endovascular aortic procedures—and maybe even after open thoracoabdominal aortic procedures.”

Hiramoto is presenting new research on this topic at the Charing Cross session on Spinal Cord Ischaemia in the Upper […]

Don’t miss: The influence of hyperglycaemia on spinal cord injury2019-09-06T16:21:31+01:00

CX 2019: Why a signed consent form “is not consent”

2019-09-06T16:22:57+01:00

Jonathan Beard, (Sheffield, UK), discusses the current medicolegal issues in the field and explains how vascular surgeons can become “the fall-guy for the inadequacies of other clinicians”. Beard touches on how the threshold for informed consent has changed “dramatically” in recent years which has led to “the death of […]

CX 2019: Why a signed consent form “is not consent”2019-09-06T16:22:57+01:00

News from CX 2019: Evidence supports safety of paclitaxel-coated devices

2019-09-06T16:23:55+01:00

At the Charing Cross International Symposium, Gary Ansel (Columbus, Ohio) moderates a global panel that includes Thomas Albrecht (Berlin, Germany), Peter Schneider (San Francisco, USA) and Eric Secemsky (Boston, USA). The panel outlines the value of paclitaxel devices in the treatment of peripheral arterial disease patients; examines new evidence on […]

News from CX 2019: Evidence supports safety of paclitaxel-coated devices2019-09-06T16:23:55+01:00

Breaking news from CX 2019: Cook leads the way to data transparency with release of long-term ZILVER PTX patient-level data

2019-09-06T16:27:30+01:00

There were several calls at the CX 2019 Highlight Session Paclitaxel: The last word on the need for a meta-analysis of individual patient-level data going forward and greater transparency and sharing of the available randomised controlled trial data of paclitaxel-coated devices.

Cook Medical has just announced the release of de-identifiable […]

Breaking news from CX 2019: Cook leads the way to data transparency with release of long-term ZILVER PTX patient-level data2019-09-06T16:27:30+01:00

Key take-aways from the CX 2019 Highlight Session on Paclitaxel: The Last Word

2019-09-06T16:28:17+01:00

Elena Ladich (Hollywood, USA) and Roger Greenhalgh (London, UK) discuss the current uncertainty surrounding the use of paclitaxel devices and the need for individual patient-level data analyses going forward to better understand the mortality signal raised by the Katsanos et al meta-analysis.

Ladich believes that “we need to take a step […]

Key take-aways from the CX 2019 Highlight Session on Paclitaxel: The Last Word2019-09-06T16:28:17+01:00

CX 2019: Stroke following cardiac surgery is a “wake-up call”; safety of carotid stenting debate

2019-09-06T16:33:28+01:00

In the Acute Stroke Challenges session on Monday, Nick Hopkins talks to CX Live about the “significant increase” of incidents of stroke following cardiac surgery which is “much more common than previously thought”.

Ross Naylor and Peter Schneider debated the impact of new technologies and innovations making carotid artery stenting as […]

CX 2019: Stroke following cardiac surgery is a “wake-up call”; safety of carotid stenting debate2019-09-06T16:33:28+01:00

CX Special Session will discuss the use of paclitaxel devices

2019-09-06T16:37:19+01:00

CX Executive Board Members Gunnar Tepe and Thomas Zeller introduce the CX Special Session which aims to give the last word on paclitaxel and work with the vascular community to find the way forward.

Watch the video below, and see the final CX 2019 programme here.

[…]

CX Special Session will discuss the use of paclitaxel devices2019-09-06T16:37:19+01:00

CX 2019: NICE AAA guidelines under the spotlight

2019-09-06T16:42:13+01:00


The publication of the draft aortic guidelines by the National Institute for Health and Care Excellence (NICE) in May 2018 raised quite a stir.

However, the story is not over. In a CX Special Session, new analysis will show what we now know about long-term EVAR outcomes, and the vascular community’s concerns over the […]

CX 2019: NICE AAA guidelines under the spotlight2019-09-06T16:42:13+01:00

CX 2019: Vascular EDUCATION as it should be

2020-02-14T14:51:28+00:00

CX is Europe’s largest and longest-running vascular symposium and delivers vascular EDUCATION as it should be

CX raises CONTROVERSIESCHALLENGES the evidence to reach CONSENSUS in a three yearly cycle after discussion involving a world-class faculty and expert audience.

CX uses both live cases and edited cases from leading aortic, peripheral and venous centres to illustrate […]

CX 2019: Vascular EDUCATION as it should be2020-02-14T14:51:28+00:00

CX 2019: The last word on the paclitaxel controversy

2019-02-07T17:15:34+00:00

Since the publication of Katsanos et al’s meta-analysis in the Journal of the American Heart Association (JAHA), the science and support for paclitaxel-releasing devices in the legs is an unfolding story.

A CX 2019 Highlight session will feature two hours of independent review of the data and in-depth debate and discussion.

CX […]

CX 2019: The last word on the paclitaxel controversy2019-02-07T17:15:34+00:00

CX 2019 Vascular Access Programme Highlights

2019-09-06T16:38:16+01:00

Nicholas Inston, member of the CX Vascular Access Executive Board, gives the highlights for this year’s CX Vascular Access Masterclass which will focus on the maintenance and not just the formation of vascular access.

CX 2019 Vascular Access Programme Highlights2019-09-06T16:38:16+01:00

CX 2019: Stephen Black on the Venous Challenges programme

2019-09-06T16:41:17+01:00

Stephen Black, member of the CX Venous Executive Board, describes the wonderful opportunity that the Charing Cross Venous Challenges Programme offers as it brings together key developments in the science, learning experience in the Venous Village and input from the international faculty who share their vision.

CX 2019: Stephen Black on the Venous Challenges programme2019-09-06T16:41:17+01:00
Go to Top